Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new PubMed-sourced publication entry under Publications for a 2025 ALLIANCE-related paper by D'Antoni ML et al. The entry includes the citation and a From PubMed note.
    Difference
    0.4%
    Check dated 2025-11-03T00:49:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T08:03:06.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Upgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T02:58:39.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added the ALLIANCE Brief Report citation (Aug 2024; DOI 10.1097/QAI.0000000000003434) and removed the Erratum entry (Oct 2024; DOI 10.1097/QAI.0000000000003494); page revision updated from v3.0.1 to v3.0.2.
    Difference
    1%
    Check dated 2025-09-13T17:37:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-06T15:21:47.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of new drug combinations and pharmaceutical preparations. Notably, the revision number has been updated to v3.0.0.
    Difference
    10%
    Check dated 2025-08-30T12:02:49.000Z thumbnail image

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.